During the last session, Hoth Therapeutics Inc (NASDAQ:HOTH)’s traded shares were 0.56 million, with the beta value of the company hitting 0.60. At the end of the trading day, the stock’s price was $0.79, reflecting an intraday gain of 1.78% or $0.02. The 52-week high for the HOTH share is $3.80, that puts it down -381.01 from that peak though still a striking 26.58% gain since the share price plummeted to a 52-week low of $0.58. The company’s market capitalization is $10.37M, and the average intraday trading volume over the past 10 days was 0.46 million shares, and the average trade volume was 865.61K shares over the past three months.
Hoth Therapeutics Inc (HOTH) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. HOTH has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.34.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Hoth Therapeutics Inc (HOTH) registered a 1.78% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.78% in intraday trading to $0.79, hitting a weekly high. The stock’s 5-day price performance is -2.10%, and it has moved by -24.27% in 30 days. Based on these gigs, the overall price performance for the year is -34.37%. The short interest in Hoth Therapeutics Inc (NASDAQ:HOTH) is 0.27 million shares and it means that shorts have 0.27 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 27.96%. While earnings are projected to return 46.59% in 2025, the next five years will return 27.65% per annum.
HOTH Dividends
Hoth Therapeutics Inc is due to release its next quarterly earnings on 2025-Mar-27. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Hoth Therapeutics Inc insiders own 0.50% of total outstanding shares while institutional holders control 1.85%, with the float percentage being 1.86%.
Also, the Mutual Funds coming in first place with the largest holdings of Hoth Therapeutics Inc (HOTH) shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund owns about 38.8 shares. This amounts to just over 0.29 percent of the company’s overall shares, with a $30562.0 market value. The same data shows that the other fund manager holds slightly less at 34.79, or about 0.26% of the stock, which is worth about $27403.0.
